| Document |
Document Title |
|
WO/2022/123530A1 |
The present invention relates to: a compound represented by chemical formula 1; a pharmaceutically acceptable salt thereof or an isomer thereof; and a pharmaceutical composition for treating or preventing proteasome-borne diseases, conta...
|
|
WO/2022/121224A1 |
The present invention relates to an organoboron-nitrogen compound, a mixture, a composition and an organic electronic device. The organoboron-nitrogen compound is represented by general formula (I) or (II). The organoboron-nitrogen compo...
|
|
WO/2022/120226A1 |
The present disclosure provides methods and related compositions that incorporate a molecularly targeted approach via the integrin subtype αvβ6 using Peptide Receptor Radionuclide Therapy (PRRT) and a theranostic approach.
|
|
WO/2022/119297A1 |
The present invention relates to a polycyclic compound which can be employed in various organic layers included in an organic light emitting device and contains R substituted with at least one deuterium (D), and to an organic light emitt...
|
|
WO/2022/118834A1 |
An indium compound represented by general formula (1). [Chemical formula 1] (In the formula, R1 and R2 each independently represent an unsubstituted C1-5 alkyl group, etc., R3 and R4 each independently represent a hydrogen atom, an uns...
|
|
WO/2022/116746A1 |
Disclosed in the present invention is a separation and recovery method for boron trifluoride and a complex thereof in an olefin polymerization reaction. The separation and recovery method comprises: 1) performing flash separation on a mi...
|
|
WO/2022/115417A1 |
Disclosed herein are NLRP3 inflammasome inhibitors and compositions thereof. Also disclosed herein are methods including administering a therapeutically effective amount of a composition comprising at least one NLRP3 inflammasome inhibit...
|
|
WO/2022/111520A1 |
The present invention provides an indium-oxygen cluster, a preparation method therefor, a quantum dot prepared therefrom and a preparation method for said quantum dot. The molecular formula of the indium-oxygen cluster is represented by ...
|
|
WO/2022/114333A1 |
Disclosed is a method for producing of 2-[18F]fluoro-4-boronophenylalanine comprising radioisotopes ([18F]FBPA), the method having a precursor with an effective leaving group and reaction conditions for high-yield synthesis of [18F]FBPA ...
|
|
WO/2022/113850A1 |
Provided is a novel compound or a near-infrared absorbing material containing said compound. Provided is: a compound represented by formula I, formula II, formula III-1, or formula III-2; a salt thereof; a solvate thereof; or a near-in...
|
|
WO/2022/108969A1 |
A method including: contacting a support material including absorbed water with trimethylaluminum (TMA) in an aliphatic hydrocarbon; removing the aliphatic hydrocarbon by distillation at a pressure greater than or equal to 0.5 atm; heati...
|
|
WO/2022/107064A1 |
The present invention relates to specific heterocyclic compounds, a material, preferably an emitter material, for an organic electroluminescence device comprising said specific heterocyclic compounds, an organic electroluminescence devic...
|
|
WO/2022/108972A1 |
The present disclosure relates to processes for forming alumoxanes and catalyst systems thereof for olefin polymerization. In at least one embodiment, a process includes forming a solution by, in an aliphatic hydrocarbon having a boiling...
|
|
WO/2022/108354A1 |
The present invention provides a novel compound, a solvate thereof, a hydrate thereof, a prodrug thereof, an isomer thereof or a pharmaceutically acceptable salt thereof, a preparation method thereof, and an antibiotic composition compri...
|
|
WO/2022/108970A1 |
A method including: preparing an alumoxane precursor from an organic oxygen source, a hydrocarbyl aluminum, and an organic solvent; heating the alumoxane precursor to form an alumoxane suspension; removing solid methylaluminoxane from th...
|
|
WO/2022/107740A1 |
Provided is a secondary battery electrode additive with which an active material can be coated without heat treatment that is performed at a high temperature for a long period of time, an alkaline component can be neutralized, and the de...
|
|
WO/2022/107840A1 |
This method for producing a hollow package includes: a step for forming a side wall on a substrate having aluminum wiring; and a step for forming a top plate portion on the side wall to produce a hollow structure that houses the aluminum...
|
|
WO/2022/104965A1 |
A boron-containing hydroxyl organic compound represented by general formula I, a preparation method therefor and an application thereof, and an organic electronic device containing the compound. By optimizing the structure of the device ...
|
|
WO/2022/108974A1 |
The present disclosure relates to supported catalyst systems for olefin polymerization, catalyst system precursors, methods of producing the precursors and catalyst systems and polyolefins formed from the catalyst systems.
|
|
WO/2022/107755A1 |
The present invention provides: a novel acridinium salt expressed by formula (I); and a method for producing this novel acridinium salt. (In the formula, R1 represents a C1-C6 alkyl group or a C1-C6 alkyloxy group; R2 represents a hydrog...
|
|
WO/2022/108971A1 |
The present disclosure relates to a precursor for making an activator in a catalyst system for olefin polymerization and methods of producing the precursor, the catalyst system, and the polyolefin. In at least one embodiment, an alumoxan...
|
|
WO/2022/109078A1 |
The present disclosure relates to novel compounds that include one or more aromatic boron-containing groups. The present disclosure further relates to pharmaceutical compositions containing such compounds, and their use in prevention and...
|
|
WO/2022/106714A1 |
The present invention relates to the radiolabelled compound of enantiomer (R, R) of 5-fluoro-3-4(-phenylpiperidin-1-yl)-1,2,3,4-tetrahydronaphth
alen-2-ol, as well as said compound for use in a method for in-vivo diagnosis of, in particu...
|
|
WO/2022/102565A1 |
The present invention provides a method for producing 4-borono-L-phenylalanine and an intermediate thereof. A method for producing a compound represented by formula (II) from a compound represented by formula (I), said method comprisin...
|
|
WO/2022/103090A1 |
The present specification provides a compound of chemical formula 1 and an organic light-emitting device comprising same.
|
|
WO/2022/103018A1 |
The present invention relates to a polycyclic compound that can be employed in various organic layers provided in an organic light-emitting device, and to a high-efficiency and long-life organic light-emitting device which comprises same...
|
|
WO/2022/097968A1 |
The present specification relates to a boron compound represented by chemical formula 1 and an organic light-emitting device including same, wherein the compound has an emission spectrum with a narrow full width at half maximum, compared...
|
|
WO/2022/099018A1 |
The present invention relates to processes of preparing PD-1/PD-L1 inhibitor (R)-1-((7-cyano-2-(3'-(3-(((R)-3-hydroxypyrrolidin-1-yl)meth
yl)-1,7-naphthyridin-8-ylamino)-2,2'-dimethylbiphenyl-3-yl)b
enzo[d]oxazol-5-yl)methyl)pyrrolidine-...
|
|
WO/2022/098397A1 |
A boron-containing proton-exchange solid support may include a proton-exchange solid support comprising an oxygen atom and a tetravalent boron-based acid group comprising a boron atom covalently bonded to the oxygen atom.
|
|
WO/2022/096495A1 |
The invention pertains to an organic molecule for use in optoelectronic devices. According to the invention, the organic molecule has: - a first chemical moiety with a structure of formula (I), - one or two second chemical moieties with ...
|
|
WO/2022/092046A1 |
The present invention pertains to an organic electroluminescent element having a positive electrode, a negative electrode, a first organic layer, and a second organic layer. The first organic layer is provided between the positive electr...
|
|
WO/2022/092602A1 |
The present invention relates to a novel compound and an MRI contrast agent containing same. The compound according to the present invention can minimize MRI contrast agent side effects caused by the release of gadolinium ions within the...
|
|
WO/2022/092068A1 |
The present invention provides a small molecule drug that is an agonist to T cell receptor CD28. Also, the present invention develops a lead compound in drug development, said lead compound being capable of suppressing autoimmune disease...
|
|
WO/2022/089415A1 |
The present invention relates to a compound and an application thereof. The compound has the structure as shown in formula (1). The compound provided in the present invention introduces substituted aryl groups containing N atoms in B-N r...
|
|
WO/2022/092260A1 |
The present invention addresses the problem of providing a cross-coupling reaction method that can use a wide variety of compounds as starting materials, that can substantially not use organic solvent, and that can rapidly provide reacti...
|
|
WO/2022/090284A1 |
The invention relates to a compound of formula (I) wherein R1; R2, R3 and R4 are as defined in the description. The invention also relates to europium (III) complexes obtained from a compound of formula (I), or from a complexing agent in...
|
|
WO/2022/089556A1 |
The present invention relates to a c-Myc protein inhibitor, a preparation method therefor, and a use thereof. The c-Myc protein inhibitor selectively inhibits a c-Myc protein, and therefore can be used in the prevention and treatment of ...
|
|
WO/2022/084505A1 |
The invention pertains to an organic molecule for use in optoelectronic devices. The organic molecule has a structure of formula (I) wherein Ra is at each occurrence independently selected from the group consisting of: hydrogen, deuteriu...
|
|
WO/2022/082990A1 |
An organic electroluminescent device and a display apparatus. The organic electroluminescent device comprises an anode, a cathode, and a light-emitting layer disposed between the anode and the cathode; the light-emitting layer comprises ...
|
|
WO/2022/085590A1 |
Provided are a light-emitting material, and an organic EL element using the same and having a high light-emission efficiency and a long lifespan. The present invention is an organic EL element including a light-emitting layer between a...
|
|
WO/2022/085714A1 |
The present invention provides a compound represented by formula (I) (in the formula: R1, R2, R3, R4, R5 and R6 represent a substituted or unsubstituted alkyl group; m's independently represent an integer of 0-4; n's independently repres...
|
|
WO/2022/079182A1 |
The invention pertains to an organic molecule with - a first chemical moiety with a structure of formula I: - and two second chemical moieties with a structure of formula II: wherein Rz is the binding site of a single bond linking the fi...
|
|
WO/2022/078431A1 |
Disclosed is a compound containing at least one structural unit of chemical formula (1) or (2). The compound contains a cross-linkable group; the photoluminescence spectrum of the compound has a relatively narrow half-peak width, and a c...
|
|
WO/2022/079068A1 |
The invention relates to cyclic compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices containing said compounds.
|
|
WO/2022/079067A1 |
The present invention relates to cyclic compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices containing said compounds.
|
|
WO/2022/078961A1 |
The invention pertains to an organic molecule for use in optoelectronic devices. The organic molecule has - a first chemical moiety with a structure of Formula I and - a second chemical moiety with a structure according to Formula II whe...
|
|
WO/2022/078434A1 |
Disclosed is a compound comprising at least one structural unit of chemical formula (1) or (2). The compound comprises an alcohol-soluble or water-soluble group. The photoluminescence spectrum of the compound has a narrower half-peak wid...
|
|
WO/2022/078432A1 |
Disclosed is a composition including at least one compound having a structural unit of chemical formula (1) or (2), and an organic resin; and the organic resin can facilitate the forming of a film by means of printing or coating methods,...
|
|
WO/2022/074616A1 |
The present invention relates to specific heterocyclic compounds, a material, preferably an emitter material, for an organic electroluminescence device comprising said specific heterocyclic compounds, an organic electroluminescence devic...
|
|
WO/2022/076070A1 |
Described herein are boron-containing compounds, compositions, and methods for their preparation.
|
